文献速递流行病学与生物统计医学教育与科研方法

观察性研究注册的范围综述发现注册政策不足、注册数量增加,且辩论趋向支持注册

Scoping review of registration of observational studies finds inadequate registration policies, increased registration, and a debate converging toward proregistration.
PubMed 文献 · J Clin Epidemiol · 2025-01-23

该范围综述检索了世界卫生组织国际临床试验注册平台全部19个成员注册机构的网站与数据库,了解观察性研究注册政策及年度注册数量,并检索2009至2023年文献分析相关论点。结果显示仅部分注册机构有明确政策,注册数量持续增加,相关辩论自2012年以来趋向支持注册。

要点

  • 19个注册机构中15个允许观察性研究注册,仅7个(35%)有明确注册内容政策。
  • 所有注册机构的观察性研究年注册量均增加,如ClinicalTrials.gov从1999年313项增至2022年9775项。
  • 50份文献中31份支持注册、18份反对、1份中立;自2012年以来25份中19份支持。

核心结论

  • 少数注册机构有观察性研究注册政策,观察性研究注册数量增加,相关辩论活跃且自2012年以来似乎趋向支持注册。

研究设计与样本

  • 范围综述:检索世界卫生组织注册网络全部19个成员注册机构的网站与数据库,了解观察性研究注册政策及每年注册数量(从注册机构建立至2022年)。
  • 检索Medline、Embase、Google Scholar及顶级医学与流行病学期刊2009至2023年文献,纳入含论点的文献,并将出现于至少3份文献的论点归类为主要论点。

主要发现

  • 19个注册机构中15个允许观察性研究注册,其中7个(35%)有明确注册内容政策,2个(11%)有明确注册时间政策。
  • 所有注册机构的观察性研究年注册量随时间增加,例如ClinicalTrials.gov从1999年313项增至2022年9775项。
  • 50份文献提供观察性研究注册相关论点:31份支持、18份反对、1份中立;自2012年以来25份中19份支持。
  • 九个论点被归类为主要论点:五个支持、四个反对;最常见的支持论点为防止结局选择性报告(n=16)和发表偏倚(n=12),最常见的反对论点为妨碍探索新想法(n=17)和浪费资源(n=6)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to examine a) the policies of national and international clinical trial registries regarding observational studies; b) the time trends of observational study registration; and c) the published arguments for and against observational study registration. STUDY DESIGN AND SETTING: Scoping review of registry practices and published arguments. We searched the websites and databases of all 19 members of the World Health Organization's Registry Network to identify policies relating to observational studies and the number of observational studies registered annually from the beginning of the registries to 2022. Regarding documents with arguments, we searched Medline, Embase, Google Scholar, and top medical and epidemiological journals from 2009 to 2023. We classified arguments as "main" based on the number (n ≥ 3) of documents they occurred in. RESULTS: Of 19 registries, 15 allowed observational study registration, of which seven (35%) had an explicit policy regarding what to register and two (11%) about when to register. The annual number of observational study registrations increased over time in all registries; for example, ClinicalTrials.gov increased from 313 in 1999 to 9775 in 2022. Fifty documents provided arguments concerning observational study registration: 31 argued for, 18 against, and one was neutral. Since 2012, 19 out of 25 documents argued for. We classified nine arguments as main: five for and four against. The two most prevalent arguments for were the prevention of selective reporting of outcomes (n = 16) and publication bias (n = 12), and against were that it will hinder exploration of new ideas (n = 17) and it will waste resources (n = 6). CONCLUSION: Few registries have policies regarding observational studies; an increasing number of observational studies were registered; there was a lively debate on the merits of registration of observational studies, which, since 2012, seems to converge toward proregistration.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Malmsiø D, Norlén S, Jespersen C, et al. Scoping review of registration of observational studies finds inadequate registration policies, increased registration, and a debate converging toward proregistration. J Clin Epidemiol. 2025. PMID: 39862933. doi:10.1016/j.jclinepi.2025.111686

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。